Cargando…

Resting-state functional MRI demonstrates brain network reorganization in neuromyelitis optica spectrum disorder (NMOSD)

BACKGROUND: The relation between brain functional connectivity of patients with neuromyelitis optica spectrum disorder (NMOSD) and the degree of disability remains unclear. OBJECTIVE: Compare brain functional connectivity of patients with NMOSD to healthy subjects in resting-state functional MRI (rs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bigaut, Kévin, Achard, Sophie, Hemmert, Céline, Baloglu, Seyyid, Kremer, Laurent, Collongues, Nicolas, De Sèze, Jérôme, Kremer, Stéphane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351056/ https://www.ncbi.nlm.nih.gov/pubmed/30695058 http://dx.doi.org/10.1371/journal.pone.0211465

Ejemplares similares

Progress in treatment of neuromyelitis optica spectrum disorders (NMOSD): Novel insights into therapeutic possibilities in NMOSD
por: Shi, Mingchao, et al.
Publicado: (2022)

White Matter Atrophy and Cognitive Dysfunctions in Neuromyelitis Optica
por: Blanc, Frederic, et al.
Publicado: (2012)

Retinal Morphology and Sensitivity Are Primarily Impaired in Eyes with Neuromyelitis Optica Spectrum Disorder (NMOSD)
por: Akiba, Ryutaro, et al.
Publicado: (2016)

General anaesthesia for caesarean section in a patient with neuromyelitis optica spectrum disorder (NMOSD)
por: Dusitkasem, Sasima, et al.
Publicado: (2019)

Sjögren’s syndrome and Neuromyelitis Optica spectrum disorders (NMOSD) – a case report and review of literature
por: Jayarangaiah, Apoorva, et al.
Publicado: (2014)

Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study
por: Tian, De-Cai, et al.
Publicado: (2020)

Evaluation of Clinical Interest of Anti-Aquaporin-4 Autoantibody Followup in Neuromyelitis Optica
por: Chanson, Jean-Baptiste, et al.
Publicado: (2013)

Rapid Discrimination of Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis Using Machine Learning on Infrared Spectra of Sera
por: El Khoury, Youssef, et al.
Publicado: (2022)

Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology
por: Fujihara, Kazuo, et al.
Publicado: (2020)

Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti–SARS-CoV-2 Antibodies: An Observational Study
por: Bigaut, Kévin, et al.
Publicado: (2021)

Corrigendum to ‘Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study’
por: Tian, De-Cai, et al.
Publicado: (2021)

Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration?
por: Motahharynia, Ali, et al.
Publicado: (2022)

Two Cases of Very-Late-Onset Neuromyelitis Optica Spectrum Disorder (NMOSD) in Patients over the Age of 80
por: Fujiwara, Shunya, et al.
Publicado: (2020)

Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): A report from Iran
por: Sahraian, Mohammad Ali, et al.
Publicado: (2020)

Clinical and prognostic aspects of patients with the Neuromyelitis Optica Spectrum Disorder (NMOSD) from a cohort in Northeast Brazil
por: Fukuda, Thiago Gonçalves, et al.
Publicado: (2022)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection
por: Bigaut, K., et al.
Publicado: (2021)

Guillain-Barré syndrome related to SARS-CoV-2 infection
por: Bigaut, Kévin, et al.
Publicado: (2020)

A case of neuromyelitis optica spectrum disorder (NMOSD) and acute myositis following SARS-CoV-2 infection
por: Barone, Stefania, et al.
Publicado: (2021)

Prevalence of COVID-19 infection in patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2021)

Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review
por: Mirmosayyeb, O., et al.
Publicado: (2023)

Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype
por: Pröbstel, Anne-Katrin, et al.
Publicado: (2015)

COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis
por: Barzegar, Mahdi, et al.
Publicado: (2022)

Sociodemographic and Illness-Related Indicators to Predict the Status of Neuromyelitis Optica Spectrum Disorder (NMOSD) Five Years after Disease Onset
por: Sadeghi-Bahmani, Dena, et al.
Publicado: (2022)

Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis
por: Jarius, Sven, et al.
Publicado: (2023)

Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023)

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
por: Wingerchuk, Dean M., et al.
Publicado: (2015)

Free thyroxine level is associated with both relapse rate and poor neurofunction in first-attack Neuromyelitis Optica Spectrum Disorder (NMOSD) patients
por: He, Qianyi, et al.
Publicado: (2019)

COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America: COVID-19 in MS and NMOSD patients in LATAM
por: Alonso, Ricardo, et al.
Publicado: (2021)

Association of neutrophil-to-lymphocyte ratio (NLR) with the prognosis of first attack neuromyelitis optica spectrum disorder (NMOSD): a retrospective cohort study
por: Xie, Haojie, et al.
Publicado: (2021)

HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data
por: Watanabe, Mitsuru, et al.
Publicado: (2021)

Neuromyelitis optica spectrum disorders: An update
por: Pandit, Lekha
Publicado: (2015)

Treatment of Neuromyelitis Optica Spectrum Disorders
por: Chan, Koon-Ho, et al.
Publicado: (2021)

Satralizumab for neuromyelitis optica spectrum disorder
Publicado: (2021)

Spectrum of sublytic astrocytopathy in neuromyelitis optica
por: Guo, Yong, et al.
Publicado: (2021)

Patients with neuromyelitis optica spectrum disorder (NMOSD) are associated with adverse outcome after total hip arthroplasty: a matched case–control study
por: Chen, Xi, et al.
Publicado: (2021)

A Case of Latent Plasmodium Falciparum Malaria in a Patient With Coexisting Systemic Lupus Erythematosus (SLE) and Neuromyelitis Optica Spectrum Disorder (NMOSD)
por: Valle, Ana, et al.
Publicado: (2022)

Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders
por: Fan, Xueli, et al.
Publicado: (2016)

Neuromyelitis-optica-Spektrum-Erkrankungen (NMOSD) und Anti-Myelin-Oligodendrozyten-Glykoprotein-Antikörper-assoziierte Erkrankungen (MOGAD)
por: Seifert-Held, Thomas
Publicado: (2022)

Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational study
por: Bigaut, Kévin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h12vep5rffmh55odm7e1miln3i